Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease
Sign Up to like & getrecommendations! Published in 2022 at "Diabetes"
DOI: 10.1111/dom.14641
Abstract: To assess the effects of dapagliflozin in patients with chronic kidney disease (CKD) and albuminuria, with and without type 2 diabetes, stratified by the Quételet (body mass) index (BMI). read more here.
Keywords: effects dapagliflozin; telet body; chronic kidney; body mass ... See more keywords